These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36655559)

  • 21. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study.
    Ali Khan U; Fallah M; Sundquist K; Sundquist J; Brenner H; Kharazmi E
    PLoS Med; 2020 Nov; 17(11):e1003431. PubMed ID: 33186354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
    BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
    Ribbing Wilén H; Saraste D; Blom J
    J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial participation as a predictor for continuous participation in population-based colorectal cancer screening.
    Saraste D; Öhman DJ; Sventelius M; Elfström KM; Blom J; Törnberg S
    J Med Screen; 2018 Sep; 25(3):126-133. PubMed ID: 28786766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
    Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
    Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].
    Rutka M; Molnár T; Bor R; Farkas K; Fábián A; Győrfi M; Bálint A; Milassin Á; Szűcs M; Tiszlavicz L; Nagy F; Szepes Z
    Orv Hetil; 2017 Oct; 158(42):1658-1667. PubMed ID: 29037058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of patients with symptom- and screening-detected colorectal cancer.
    Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
    Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of non-participation in a mass screening program for colorectal cancer in Finland.
    Artama M; Heinävaara S; Sarkeala T; Prättälä R; Pukkala E; Malila N
    Acta Oncol; 2016 Jul; 55(7):870-4. PubMed ID: 27152755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of the population-based pilot colorectal cancer screening, Csongrád county, Hungary, 2015.
    Rutka M; Bor R; Molnár T; Farkas K; Pigniczki D; Fábián A; Györffy M; Bálint A; Milassin Á; Szücs M; Tiszlavicz L; Nagy F; Szepes Z
    Turk J Med Sci; 2020 Jun; 50(4):756-763. PubMed ID: 32151116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
    Breekveldt ECH; Toes-Zoutendijk E; de Jonge L; Spaander MCW; Dekker E; van Kemenade FJ; van Vuuren AJ; Ramakers CRB; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    BMC Gastroenterol; 2023 Feb; 23(1):45. PubMed ID: 36814185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Participation and yield of a population-based colorectal cancer screening programme in China.
    Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
    Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptance on colorectal cancer screening upper age limit in South Korea.
    Luu XQ; Lee K; Lee YY; Suh M; Kim Y; Choi KS
    World J Gastroenterol; 2020 Jul; 26(27):3963-3974. PubMed ID: 32774070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study.
    Baldacchini F; Bucchi L; Giuliani O; Mancini S; Ravaioli A; Vattiato R; Zamagni F; Giorgi Rossi P; Mangone L; Campari C; Sassatelli R; Trande P; Esposito P; Rossi F; Carrozzi G; Triossi O; Fabbri C; Strocchi E; Giovanardi M; Canuti D; Sassoli de Bianchi P; Ferretti S; Falcini F;
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2373-2382. PubMed ID: 35144023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening.
    Stegeman I; van Doorn SC; Mundt MW; Mallant-Hent RC; Bongers E; Elferink MA; Fockens P; Stroobants AK; Bossuyt PM; Dekker E
    Cancer Epidemiol; 2015 Jun; 39(3):388-93. PubMed ID: 25910865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.
    Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E
    BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
    Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
    Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
    Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.